These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 11279868)
1. Oral contraceptive therapy in women: drug interactions and unwanted outcomes. Schwartz JB J Gend Specif Med; 1999; 2(6):26-9. PubMed ID: 11279868 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk. Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951 [TBL] [Abstract][Full Text] [Related]
3. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Tanis BC; Rosendaal FR Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494 [TBL] [Abstract][Full Text] [Related]
13. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [TBL] [Abstract][Full Text] [Related]
20. Reduced oral contraceptive effectiveness with concurrent antibiotic use: a protocol for prescribing antibiotics to women of childbearing age. Donley TG; Smith RF; Roy B Compendium; 1990 Jun; 11(6):392-6. PubMed ID: 2083416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]